The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

被引:0
作者
L. Susok
S. Said
D. Reinert
R. Mansour
C. H. Scheel
J. C. Becker
T. Gambichler
机构
[1] Ruhr-University Bochum,Skin Cancer Center, Department of Dermatology
[2] Ruhr-University Bochum,Department of Radiology
[3] University Duisburg-Essen,Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, Dermatology
[4] German Cancer Research Center (DKFZ),undefined
来源
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词
Cutaneous melanoma; Immune checkpoint inhibitors; Ipilimumab; Pembrolizumab; Nivolumab; Pan-immune-inflammation value; Systemic immune-inflammation index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3103 / 3108
页数:5
相关论文
共 81 条
[1]  
Bai X(2021)Risk models for advanced melanoma patients under anti-PD-1 monotherapy-ad hoc analyses of pooled data from two clinical trials Front Oncol 11 639085-247
[2]  
Dai J(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 1 228-409
[3]  
Li C(2018)Reference values for white blood-cell-based inflammatory markers in the Rotterdam study: a population-based prospective cohort study Sci Rep 8 10566-536
[4]  
Eisenhauer EA(2020)The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials Br J Cancer 123 403-317
[5]  
Therasse P(2021)The pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy Target Oncol 16 529-681
[6]  
Bogaerts J(2021)Dynamics of clinical biomarkers as predictors of immunotherapy benefit in metastatic melanoma patients Clin Transl Oncol 23 311-921
[7]  
Fest J(2016)Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma J Dtsch Dermatol Ges 14 662-35299
[8]  
Ruiter R(2018)Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV mela-noma J Surg Oncol 118 915-3040
[9]  
Ikram MA(2018)Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors Oncotarget 9 35293-353
[10]  
Voortman T(2015)Inflammation fuels tumor progress and metastasis Curr Pharm Des 21 3032-12470